Immuneering (IMRX) Accounts Payables (2020 - 2024)

Immuneering (IMRX) has 5 years of Accounts Payables data on record, last reported at $1.9 million in Q3 2024.

  • For Q3 2024, Accounts Payables changed 0.09% year-over-year to $1.9 million; the TTM value through Sep 2024 reached $1.9 million, changed 0.09%, while the annual FY2023 figure was $2.1 million, 33.06% down from the prior year.
  • Accounts Payables reached $1.9 million in Q3 2024 per IMRX's latest filing, down from $2.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $3.2 million in Q4 2022 and bottomed at $1.2 million in Q2 2022.
  • Average Accounts Payables over 5 years is $2.1 million, with a median of $1.9 million recorded in 2024.
  • Peak YoY movement for Accounts Payables: soared 126.24% in 2022, then tumbled 33.06% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $1.5 million in 2020, then dropped by 5.82% to $1.4 million in 2021, then skyrocketed by 126.24% to $3.2 million in 2022, then crashed by 33.06% to $2.1 million in 2023, then dropped by 8.0% to $1.9 million in 2024.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $1.9 million in Q3 2024, $2.6 million in Q2 2024, and $2.3 million in Q1 2024.